The new regulatory data protection system may serve as an incentive for the development of incrementally modified drugs, leading to enhanced R&D capabilities in the pharmaceutical industry.
ARTICLES & NEWS
New Korean regulatory data protection system allows reinforced data exclusivity for pharmaceuticals
